Expertise in
1
conditions

Hans G. Van Der Hoeven-Van Der Voet

Godesberger Allee 64, 
Bonn, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Godesberger Allee 64, 
Bonn, NW, DE 
OverviewLocationsClinical Research

Overview

Hans Van Der Hoeven-Van Der Voet practices in Bonn, Germany. Mr. Van Der Hoeven-Van Der Voet is highly rated in 1 condition, according to our data. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, Pancreaticoduodenectomy, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 73 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Godesberger Allee 64, Bonn, NW 53175, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MONITOR-IC: a Mixed Methods Multicenter Prospective Open Cohort Study Determining and Improving Long-term Outcomes of ICU Survivors
MONITOR-IC: a Mixed Methods Multicenter Prospective Open Cohort Study Determining and Improving Long-term Outcomes of ICU Survivors
Enrollment Status: Recruiting
Publish Date: December 27, 2023
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis
The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis
Enrollment Status: Completed
Publish Date: January 16, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

72 Total Publications

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Journal: The Lancet. Oncology
Published: December 20, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Der Hoeven-Van Der Voet's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile